Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

USD 36.0

(-7.98%)

Inventory Summary of Biohaven Pharmaceutical Holding Company Ltd.

  • Biohaven Pharmaceutical Holding Company Ltd.'s latest annual inventory in 2023 was - USD , down -100.0% from previous year.
  • Biohaven Pharmaceutical Holding Company Ltd.'s latest quarterly inventory in 2024 Q1 was - USD , down 0.0% from previous quarter.
  • Biohaven Pharmaceutical Holding Company Ltd. reported annual inventory of 56.15 Million USD in 2022, up 733.93% from previous year.
  • Biohaven Pharmaceutical Holding Company Ltd. reported annual inventory of 6.73 Million USD in 2021, down -82.98% from previous year.
  • Biohaven Pharmaceutical Holding Company Ltd. reported quarterly inventory of - USD for 2024 Q2, down 0.0% from previous quarter.
  • Biohaven Pharmaceutical Holding Company Ltd. reported quarterly inventory of 87.94 Million USD for 2023 Q1, up 56.61% from previous quarter.

Annual Inventory Chart of Biohaven Pharmaceutical Holding Company Ltd. (2023 - 2017)

Historical Annual Inventory of Biohaven Pharmaceutical Holding Company Ltd. (2023 - 2017)

Year Inventory Inventory Growth
2023 - USD -100.0%
2022 56.15 Million USD 733.93%
2021 6.73 Million USD -82.98%
2020 39.56 Million USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%

Peer Inventory Comparison of Biohaven Pharmaceutical Holding Company Ltd.

Name Inventory Inventory Difference
ADC Therapeutics SA 16.17 Million USD 100.0%
Alto Neuroscience, Inc. - USD NaN%
Annovis Bio, Inc. - USD NaN%
Ginkgo Bioworks Holdings, Inc. 46 Thousand USD 100.0%
Nuvation Bio Inc. - USD NaN%
Nuvation Bio Inc. - USD NaN%
Arcus Biosciences, Inc. - USD NaN%
Theriva Biologics, Inc. - USD NaN%
Zymeworks Inc. 1.00 USD 100.0%